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Abstract We have identified, characterized and cloned human, 
mouse and chicken cDNA of a novel protein that binds to the Src 
homology domain 3 (SH3) of the Yes proto-oncogene product. 
We subsequently named it YAP for Yes-associated protein. Anal- 
ysis of the YAP sequence revealed a protein module that was 
found in various structural, regulatory and signaling molecules. 
Because one of the prominent features of this sequence motif is 
the presence of two conserved tryptophans (W), we named it the 
WW domain. Using a functional screen of a cDNA expression 
library, we have identified two putative ligands of the WW do- 
main of YAP which we named WBP-1 and WBP-2. Peptide 
sequence comparison between the two partial clones revealed a 
homologous proline-rich region. Binding assays and site-specific 
mutagenesis have shown that the proline-rich motif binds with 
relatively high affinity and specificity to the WW domain of YAP, 
with a preliminary consensus that is different from the SH3- 
binding PXXP motif. This suggests that the WW domain has a 
role in mediating protein-protein interactions via proline-rich 
regions, similar but distinct from Src homology 3 (SH3) domains. 
Based on this finding, we hypothesize that additional protein 
modules exist and that they could be isolated using proline-rich 
peptides as functional probes. 
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1. Background and rationale - Retrospective look 
What started as a pilot project ended up being the main 
focus of an entire lab. Our general aim has been to decipher 
molecular steps of signaling by the Yes proto-oncogene product 
which represents a non-receptor type protein-tyrosine kinase of 
the Src family [1]. The specific goal was to isolate substrates and 
regulators of the Yes kinase in order to understand at least 
some aspects of the molecular ole it plays in normal and the 
viral-Yes oncogene transformed cells [2]. Initially, our experi- 
mental approaches were descriptive of nature [3,4]. We argued 
that by characterizing the pattern of Yes expression in various 
tissues and cells, we would have been able to find a common 
denominator that would provide a clue regarding the physio- 
logical function of the Yes protein [5]. Localization of the Yes 
proto-oncogene transcript and protein in cerebellar Purkinje 
cells was an exciting finding which gave us hope for functional 
clues [6]. Unfortunately, that was immediately followed by the 
frustration of trying to study the Yes kinase in difficult exper- 
imental systems of isolated Purkinje neurons or cerebellar 
slices. The direction of our research activities hifted swiftly 
when Hirai and Varmus proposed that the amino termini of Src 
family kinases form complexes with cellular proteins and that 
these apparently transient and dynamic complexes constitute 
a part of the mechanism by which Src, Yes and other kinases 
signal [7]. The SH2 domain, residing at the amino terminal half 
of the Src kinases had already been delineated at that time and 
was a primary candidate for a signaling domain [8]. The pro- 
posal of Hirai and Varmus had two attractive lements. (i) It 
agreed with a number of observations from other labs including 
that of Hanafusa nd colleagues [9]. (ii) Implicitly, it promised 
a molecular explanation for specificity in action for members 
of the Src family whose sequences diverged most at the very 
amino terminal regions (specifically at their 'finger print' [1] or 
unique domains). 
In order to isolate proteins that interact with the Yes kinase, 
we decided to use anti-idiotypic antibodies directed to the 
amino terminal domain of the Yes protein expressed in bacteria 
[10,11]. Although controversial nd risky as far as the well- 
defined molecular probes are considered, the anti-idiotypic an- 
tibodies have been known in some instances to mimic, perhaps 
in most of the cases only partially, the structure of the original 
epitope [12]. Our original antigen was composed of the unique 
and SH3 domain of the Yes protein expressed in bacteria. Its 
epitope seemed to reside mostly in the SH3 domain of Yes (see 
the discussion in [11]). Using the anti-idiotypic antibodies and 
lambda phage expression library from cerebellar Purkinje cells, 
we isolated one cDNA clone that encoded a new proline- 
rich protein that we named Yes-Associated Protein (YAP) [11]. 
We showed that YAP interacts with the SH3 domain of Yes 
and other signaling molecules through a proline rich sequence 
[11]. It was through the detailed characterization f YAP that 
we obtained clues to a novel protein module that we named the 
WW domain. 
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2. YAP is a proline-rich phosphoprotein that binds to SH3 
domains 
YAP is of 65 kDa molecular mass, it is phosphorylated in 
vivo on serine and is particularly rich in proline [11]. Within the 
YAP sequence we have identified a motif, PVKQPPPLAP that 
is in agreement with the consensus proposed by Schreiber and 
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Fig. l. Phylogenetic tree of the selected WW domains [14,15] constructed using the method of progressive sequence alignment [30]. Instead of 
comparing the entire domains, variable residues (see the consensus) were omitted to reduce the background. The numbers represent the proportional 
lengths of the horizontal line segments, or the phylogenetic distance between sequences. Line segments without numbers represent scores of-0.0, 
or a negligible distance (often sequences with identical consensus). 
colleagues for the 'Class I Sequences' of SH3-binding motifs 
with PXXP motif predicted at positions 7 and 10: 
PVKQPPPLAP [13]. Competition assays with synthetic pep- 
tides showed the involvement of the predicted proline-rich se- 
quence in binding between YAP and the Yes kinase. Interest- 
ingly, YAP was also shown to bind other signaling molecules 
that contain SH3 domains including Nck, Crk and Src, and to 
lesser extent o the SH3 domains of Abl and GAP (guanosine 
triphosphatase activating protein). The specific sites of serine 
phosphorylation YAP are being mapped at present. One of 
the attractive candidates for the kinase phosphorylating YAP 
is the MAP kinase. A consensus site for the MAP kinase phos- 
phorylation ispresent just at the carboxyl end of the proline-rich 
domain of YAP. We do not know whether YAP phosphoryla- 
tion could affect its binding to SH3 domains. However, it is 
tempting to speculate that a negatively-charged phosphate 
group on serine residue located close to the polyproline domain 
could in fact modulate (disrupt or enhance) the proline-rich 
motif-SH3 domain interaction i  vivo as a means of regulating 
the process of signal propagation. 
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Yap/Mousel  VPLPAGWEMAKTSS-GQRYFLNHNDQTTTWQDPRKAMLS X80508 
Yap/Mouse2 GPLPDGWEQAMTQD-GEVYYINHKNKTTSWLDPRLDPRF X80508 
Dmd/Human TSVQGPWERAISPN-KVPYYINHETQTTCWDHPKMTELY PI1532 
WW consensus LPtGWE ttt Gt YYhNH TtTTtW tPt 
Orf2/Human RTVNEPWTMGFSKSFKKKFFYNKKTKDSTFDLPADSIAP D43949 
Yf43/Human YDSADDWSEHISSS-GKKYYYNCRTEVSQWEKPKEWLER R16603 
Yg46/Human XXLPPXWEKRMSRSSGRVYYFNHITNASQWERPSGNSSS R20490 
X132/Human ......... VWDENTGCYYYWNTQTNEVTWELPQYLATQ Z36787 
Fig. 2. Alignment of the WW domains of mouse YAP, human dystrophin and 4 new entries retrieved from the data base. Database accession umbers 
are given in the last column. The consensus line shown is based on the alignment of all previously described WW modules (h, hydrophobic position; 
t, turn-like or polar position). For more information about he new and other WW domains and their protein products ee 'The WW Domain Page' 
available from the www network (the address i  in the text). 
In chicken embryo fibroblasts, YAP protein was localized by 
immunofluorescent staining to cytoplasm and nucleus (Sudol, 
M., unpublished). Interestingly, the cytoplasmic staining with 
YAP antibodies was reminiscent of the picture obtained with 
Yes antibodies - the staining patterns suggested colocalization of
Yes and YAP proteins to the membranes of the endoplasmic 
reticulum. Although the nuclear staining of YAP was distinct 
and was observed with two different preparations of the affinity 
purified IgG, the final conclusion regarding its localization 
requires further confirmation by cell fractionation. 
Human and mouse orthologues of the chicken YAP were 
cloned and characterized [14]. The analysis of coding sequences 
together with the data of Southern blot analysis revealed that 
the human YAP gene is well conserved among higher Eukaryo- 
tes but may not be conserved in yeast [14]. The expression 
of YAP at the RNA level in adult human tissues is nearly 
ubiquitous, being relatively high in placenta, prostate, ovary and 
testis, but is not detectable in peripheral blood leukocytes. 
Using fluorescence in situ hybridization on human metaphase 
chromosomes and by analyzing rodent-human hybrids by 
Southern blot hybridization and PCR amplification, we 
mapped the human YAP gene to chromosome band 1 lq13, a 
region to which the multiple endocrine neoplasia type 1 gene 
has been mapped [14]. Taken together, the relatively high ex- 
pression of YAP in tissues regulated predominantly by steroid 
hormones, the presence of YAP protein in the cytoplasm and 
in the nucleus, plus the possible involvement of YAP in the 
multiple ndocrine neoplasia, a syndrome affecting polypeptide 
hormone producing tissues, could suggest hat YAP is a part 
of signaling pathways for steroid and/or polypeptide hormones. 
3. Murine YAP provides a clue for the WW domain 
Sequence comparison between mouse, human, and chicken 
YAP proteins howed an inserted sequence in the mouse YAP that 
represented a non-identical repeat of the upstream sequence 
[14]. Further analysis of this sequence revealed that it is a new 
protein module: the WW domain (named after two tryptophans 
that mostly contributed to the signal in sequence comparisons) 
[15]. Shortly thereafter, two other groups independently re- 
ported the identification of this conserved omain [16,17]; the 
widespread occurrence in otherwise different intracellular regu- 
latory proteins and the arrangement in tandem arrays of up to 
4 copies within a protein (for an overview see [14,15,18]) justify 
the term module [19]. The domain appears to contain beta- 
strands grouped around four conserved aromatic positions 
([15,17], H. Oschkinat, personal communication). Other impor- 
tant features of the domain are a high content of polar amino 
acids and the presence of prolines distributed preferentially 
towards both termini of the linear sequence. One of the C- 
terminal prolines seems strictly invariant. The length of 
the WW domain is aproximately 38 residues as suggested by the 
length of the second WW module (the insert) identified in the 
mouse ortholog of YAP [14]. As NMR spectra of the WW 
domain of YAP (collaboration with laboratories of Hartmut 
Oschkinat and Matti Saraste, EMBL, Heidelberg, Germany) 
indicate a globular structure, the size of the WW module 
appears relatively small compared with SH2, SH3 or PH 
domains. 
Examination of the primary sequences indicated that WW 
domains of YAP [14], Nedd-4 [20], and Rsp5 [21] show more 
similarity to each other than to WW domains of other proteins 
(Fig. 1). It is likely that these domains hare certain functional 
features; for example, they could interact with similar ligands 
or localize the proteins to similar cellular compartments. When 
the repeats of the WW domains within the same protein are 
examined, the second or third WW domain does not necessarily 
show as high a sequence similarity to the first WW domain as 
one would expect from a recent evolutionary duplication event, 
but does show a high similarity to WW domains of other pro- 
teins. For example, the second domain in mouse YAP is more 
similar to one of the WW domains of the yeast Rsp5 gene 
product han to the first domain in mouse YAP (Fig. 1). This 
suggests that multiple WW domains within the same molecule 
may not be redundant but could have evolved to carry out 
subtly diverged functions. 
After the initial delineation of the WW domain in animals 
[15-17], numerous additional sequences appeared in sequence 
databases that harbored a WW module [14,18]. Our most re- 
cent database searches identified yet another 4 distinct proteins 
that host a WW domain (Fig. 2). Thus, as many as 20 distinct 
proteins (taken species redundancy aside) have been described 
so far to contain this conserved module. Anticipating the num- 
ber of WW sequences to grow rapidly, we have been providing 
updated information on the WW domain via world wide web 
(www) (http://www.embl-heidelber.de/~bork/wwl.html) since 
December 1994, including both the alignment and a diagram 
with modular structure of the corresponding proteins. 
The current list of proteins with the WW motifs confirmed 
our initial conclusion that like SH2, SH3 and PH domains [22], 
the WW domain occurs in a variety of structural and signaling 
molecules with no apparent common functions [15]. Three pro- 
teins that contain the WW domain could provide a clue to one 
of the roles of this module in major signaling pathways. One 
of the human proteins, named ORF 1, [database accession um- 
ber D29640], contains a WW domain just upstream from the 
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C-terminal sequence that shows similarity to yeast Ras GTPase 
activator protein. A nematode (C. elegans) protein named 38D4 
[Z46241] harbors a WW domain at the amino terminus, fol- 
lowed by a PH domain in the middle and a C-terminal sequence 
that is conserved in the breakpoint cluster region (BCR), n- 
chimaerin, and p85 subunit of the phosphoinositol 3-kinase. A 
gene product named Msbl, with one WW domain, was isolated 
in a genetic screen in yeast and was implicated in the MAP 
kinase pathway (K. Matsumoto, personal communication). 
Taken together these data suggest an involvement of the WW 
domain in the Ras and/or MAP kinase signaling pathways. 
The function of the WW domain in YAP and in other pro- 
teins remains to be determined. The occurrence of the domain 
in yeast proteins provides a powerful genetic system that could 
be employed to analyze the function of the WW motif in vivo. 
The Rsp5 gene was identified as a suppressor of mutations 
in the SPT3 gene, which encodes a transcription factor that 
interacts with TATA-binding protein [21]. It is unlikely that 
Rsp5 and SPT3 proteins interact directly, since Rsp5 mutations 
suppress a deletion of SPT3. It is more likely that this interac- 
tion is indirect because the Rsp5 gene was recently isolated by 
researchers in several other labs studying various aspects of 
cytoplasmic signaling in yeast. One of the explanations for this 
apparent diversity of roles in signaling could come from bio- 
chemical studies of Rsp5, showing that its catalytic domain 
(designated HECT) can form a high energy thio-ester bond 
with ubiquitin, therefore proving that the Rsp5 protein is in- 
deed a ubiquitin-protein ligase [23,24]. It is likely that Nedd-4, 
a gene whose expression is modulated uring early develop- 
ment of the central nervous system, encodes the similar enzy- 
matic activity as Rsp5. Since ubiquitination is directly related 
to protein metabolism, and the WW domains in Rsp5 and 
Nedd-4 could be considered as molecular adhesive to anchor 
the ligase to the appropriate targets, one could speculate that 
a ligand for the WW domain, in general, is of proteinaceous 
nature and that this domain represents a module mediating 
protein-protein i teraction. Our recent data on the isolation of 
ligands for the WW of YAP confirm this assumption. 
4. The WW domain of YAP binds a novel proline-rich ligand 
Using a functional screen of a cDNA expression library, we 
have identified two putative ligands of the WW domain of YAP 
which we named WBP-1 and WBP-2 [25]. Peptide sequence 
comparison between the two partial clones revealed a homolo- 
gous region consisting of a proline-rich domain. Interestingly, 
binding assays and site-specific mutagenesis have shown that 
the 10 amino acid long proline-rich domain binds with rela- 
tively high affinity and specificity to the WW domain of YAP, 
with the preliminary consensus that clearly differs from the 
PXXP motif [25]. Accordingly, WBP-1 does not bind to the 
SH3 domains of arbitrarily chosen proteins including SH3 do- 
main of Yes, Fyn, Abl and GAE We have also shown that 
bacterially expressed WW domain of YAP is able to precipitate 
one or two low-molecular-weight proteins from organ or cell 
culture lysates [25]. Using similar approaches, our data also 
suggests a protein that specifically interacts with the WW do- 
main of dystrophin. Judging from the molecular-weight deter- 
mination, the ligand for the WW of dystrophin differs from the 
WBP-1 and WBP-2 proteins (Bougeret, C., Chen, H. and 
Sudol, M., unpublished). The data stronly supports a role of 
the WW domain in mediating specific protein-protein i terac- 
tions and indicates a binding activity of proline-rich ligands 
distinct from Src homology (SH3) domains. One has to await 
structural data to compare the binding mode with the SH3- 
PXXP complex and the poly-proline interaction described re- 
cently for profilin [26]. 
5. Significance and possible ramifications for medicine 
A new group of modular tyrosine kinase-associated proteins 
with multiple protein-binding domains and no apparent cata- 
lytic activity has gained considerable interest. These proteins, 
including Crk, Shc, Nck and Grb2, act as adaptor molecules that 
are charged with the responsibility of bringing together various 
components of a pathway by virtue of protein-binding domains 
such as SH2 and SH3 in order to propagate the signal. YAR 
although still unknown in function, possesses not only a WW 
domain but also a proline-rich domain that binds to the SH3 
domain of Yes. The FE65 factor cloned and characterized by 
Tommaso Russo laboratory at the University of Naples [27] 
contains one WW domain and two PID/PTB (phosphotyrosine- 
interacting/-binding) domains [28]. YAP and FE65 may in fact 
represent examples of a new family of adaptor molecules 
[25,28]. Nonetheless, at this time the biological significance of 
the interaction between the WW domain and the proline-rich 
motif of the WBP-1 is not clear. The genetic manipulation of 
the WW module in dystrophin, a molecule that has been impli- 
cated in a specific disease phenotype, (Duchenne's and Becker's 
muscular dystrophy) and other genetic approaches to analyze 
the WW domain of the yeast protein Rsp5 should provide us 
with useful biological analogies and perhaps with strategies to 
control certain muscular diseases in humans. 
6. Future trends 
Since the WW domain and the recently characterized PID/ 
PTB domain [28] represent fairly large modular families, it is 
likely that many more of such modules and their families will 
be found in the future [29,19]. The history of the WW domain 
shows that the characterization f a module by a combination 
of sensitive sequence analysis methods and various experimen- 
tal approaches i extremely powerful and can guide further 
exploration of the involved proteins and pathways; one obvious 
approach that is apparent from our data is to use various 
proline- rich polypeptides as functional probes in search of 
new, biologically relevant, protein modules. 
Acknowledgements: We thank all members of the Laboratory of Molec- 
ular Oncology for stimulating discussions and Drs. Hidesaburo Hana- 
fusa, Matti Saraste and Hartmut Oschkinat for valuable advice. The 
work from our laboratory that was reviewed in this paper was sup- 
ported by grants from: The National Cancer Institute (CA01605), The 
Council for Tobacco Research USA (3035), The Klingenstein Award, 
and by the Human Frontier Science Program Grant (to M.S.) and by 
NIH Grant (5T32GM07739-16) (to H.I.C.). 
References 
[1] Sudol, M. (1993) in: The Molecular Basis of Human Cancer (Neel, 
B. and Kumar, R., Eds.) Futura, New York, pp. 203-224. 
[2] Sudol, M. (1990) Exp. Med. 8, 94-100. 
[3] Sudol, M. and Hanafusa, H. (1986) Mol. Cell. Biol. 6, 2839 
2846. 
Marius Sudol et al. I FEBS Letters 369 (1995) 67-71 71 
[4] Sudol, M., Alvarez-Buylla, A. and Hanafusa, H. (1988) Oncogene 
Res. 2, 345-355. 
[5] Zhao, Y-H., Krueger, J. and Sudol, M. (1990) Oncogene 5, 1629- 
1635. 
[6] Sudol, M., Kuo, F.C., Shigemitsu, L. and Alvarez-Buylla, A. 
(1989) Mol. Cell. Biol. 9, 4545M549. 
[7] Hirai, H. and Varmus, H. (1990) Mol. Cell. Biol. 10, 1307 1318 
[8] Sadowski, I., Stone, J.C. and Pawson, T. (1986) Mol. Cell. Biol. 
6, 43964408. 
[9] Hanafusa, H. (1989) in: Proceedings of XXXIII Conference on 
Membrane Proteins: Targeting and Transduction, Houston, TX, 
pp. 237 245. 
[10] Jerne, N.K. (1974) Ann. Immunol. (Inst. Pasteur) 125C, 373 389. 
[11] Sudol, M. (1994) Oncogene 9, 2145-2152. 
[12] Strosberg, A.D. (1989) Methods Enzymol. 178, 265-275 
[13] Feng, S., Chen, J.K., Yu, H., Simon, J.A. and Schreiber, S.L. 
(1994) Science 266, 1241 1247. 
[14] Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, 
M., Huebner, K. and Lehman, D. (1995) J. Biol. Chem. 270, June 
issue. 
[15] Bork, P. and Sudol, M (1994) Trends Biochem. Sci. 19, 531-533. 
[16] Andr6, B. and Springael, J.-Y. (1994) Biochem. Biophys. Res. 
Commun. 205, 1201-1205. 
[17] Hofmann, K. and Bucher, R (1995) FEBS Lett. 358, 153-157. 
[18] Bork, R and Sudol, M. (1995) Trends Biochem. Sci. 20, 54. 
[19] Bork, R and Bairoch, A. (1995) Trends Biochem. Sci. 20, poster 
March issue. 
[20] Kumar, S., Tomooka, Y. and Noda, M. (1992) Biochem. Biophys. 
Res. Commun. 185, 1155 1161. 
[21] Eisenmann, M.D., Arndt, K.M., Ricupero, S.L., Rooney, J.W. 
and Winston, F. (1992) Genes Dev. 6, 1319 1332. 
[22] Musacchio, A., Wilmanns, M. and Saraste, M. (1994) Prog. Bio- 
phys. Mol, Biol. 61,283~97. 
[23] Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley. R 
(1993) Cell 75,495-505. 
[24] Huibregtse, J.M., Scheflher, M., Beaudenon, S. and HoMey, R 
(1995) Proc. Natl. Acad. Sci. USA, in press. 
[25] Chen, H.I, and Sudol, M. (1995) Proc. Natl. Acad. Sci. USA, in 
press. 
[26] Cedergren-Zeppezauer, E.S., Goonesekere, N.C.W., Rozycki, 
M.D., Myslik, J.C., Dauter, Z., Lindberg, U. and Schutt, C.E. 
(1994) J. Mol. Biol. 240, 459M75. 
[27] Duilio, A., Zambrano, N., Mogavero, A.R., Ammendola, R., 
Cimino, F. and Russo, T. (1991)Nucleic Acid. Res. 19, 5269-5274. 
[28] Bork, R and Margolis, B. (1995) Cell 80, 693~94. 
[29] Cohen, G.B., Ren, R. and Baltimore, D. (1995) Cell 80, 237 
248. 
[30] Feng, D.-F. and Doolittle, R.F. (1987) J. Mol. Evol. 25. 351 360. 
